Molecular basis of T-cell dysfunction in melanoma.
Melanoma Res
; 7 Suppl 2: S51-7, 1997 Aug.
Article
em En
| MEDLINE
| ID: mdl-9578417
ABSTRACT
Human melanoma is an immunogenic tumour which is characterized by a number of defined tumour-associated antigens and a specific T-cell-mediated immune response. Nevertheless, there is only limited evidence for an effective antitumour immune response able to eradicate established melanoma. Thus, the existence of an immunologically suppressed state in the tumour-bearing host has become an axiom in tumour immunology. There is increasing evidence that abnormalities in signal transduction events involved in cell activation are the molecular basis for the observed T-cell dysfunction. These abnormalities include altered patterns of protein tyrosin phosphorylation, decreased protein levels of the Src-family kinases p56(lck) and p59(lyn), and of the CD3zeta chain. Furthermore, differences in the expression of transcription factors of the nuclear factor NF-kappaB/Rel family have been described.
Buscar no Google
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Linfócitos T
/
Melanoma
Limite:
Humans
Idioma:
En
Ano de publicação:
1997
Tipo de documento:
Article